Endothelial cell effects of cytotoxics: balance between desired and unwanted effects
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 30 (6) , 495-513
- https://doi.org/10.1016/j.ctrv.2004.05.003
Abstract
No abstract availableKeywords
This publication has 116 references indexed in Scilit:
- Therapeutic stem and progenitor cell transplantation for organ vascularization and regenerationNature Medicine, 2003
- Capecitabine as first-line treatment in colorectal cancerEuropean Journal Of Cancer, 2002
- Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levelsAnnals of Oncology, 2002
- ‘Accidental’ anti-angiogenic drugs: anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examplesEuropean Journal Of Cancer, 2000
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in miceEuropean Journal Of Cancer, 1995
- Doxorubicin in advanced breast cancer: Influence of schedule on response, survival and quality of lifeEuropean Journal Of Cancer, 1992
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971